The journal retracts the 11 August 2021 article cited above.
Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers in Chemistry and the Chief Executive Editor of Frontiers. The authors do not agree with this retraction.
Summary
Citation
Frontiers Editorial Office (2025) Retraction: The use of bionic prodrugs for the enhancement of low dose radiotherapy. Front. Chem. 13:1754951. doi: 10.3389/fchem.2025.1754951
Received
26 November 2025
Accepted
26 November 2025
Published
08 December 2025
Approved by
Michael Kassiou, The University of Sydney, Australia
Volume
13 - 2025
Updates
Copyright
© 2025 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.